ReIMAGINE Prostate Cancer Screening Study:
Could MRI give us the first reliable population screening for prostate cancer?

 

Co Chief-Investigators: Professor Mark Emberton and Professor Caroline Moore
Sample size: 300

 

In this study MRI will be tested out in the community for the first time to see how well it detects prostate abnormalities in 300 men aged 60 to 75 who have no history of prostate cancer.

Professor Emberton said: “We will be testing if the MRI can be used for screening men and we hope that it will detect serious cancers earlier that are currently missed. If we can detect cancers earlier and more reliably with a non-invasive test, this could help to improve the survival rates to prostate cancer, which kills about 11,800 men in the UK annually.

MRI scanning for prostate cancer could also help a quarter of a million men, maybe up to half a million men a year, to avoid an unnecessary biopsy if the MRI is negative. The majority of men will be reassured they don’t have prostate cancer and importantly they may be able to avoid the harms of a biopsy, plus healthcare systems will be able to avoid the costs. MRI is the perfect tool because it’s relatively cheap, widely available and reliable.”

 

This study is now closed to recruitment.

 

Screening study sites:

  • University College London Hospitals NHS Foundation Trust 

  • Hampstead Group Practice 

  • Parliament Hill Medical Centre 

  • Prince of Wales Medical Centre 

  • The Keats Group Practice 

  • Bellingham Green surgery 

  • Minet Green Health Practice 

  • Mathukia's Surgery 

  • The Rise Group Practice 

  • The Bromley Common Practice 

  • The Exchange Surgery 

  • The Hambleden Clinic 

More information can be found here: ReIMAGINE Prostate Cancer Screening - Full Text View - ClinicalTrials.gov